Literature DB >> 34961034

Antifungal Activity against Fusarium oxysporum of Botanical End-Products: An Integration of Chemical Composition and Antifungal Activity Datasets to Identify Antifungal Bioactives.

Diego Cárdenas-Laverde1, Ricardo Barbosa-Cornelio1, Ericsson Coy-Barrera1.   

Abstract

Plants produce various compounds as defensive barriers to naturally control fungal diseases. Among them, vascular wilt caused by Fusarium oxysporum is one of the most destructive diseases in crops, causing relevant economic losses. The application of synthetic fungicides is the most used management for this disease. However, this kind of method also involves adverse environmental impacts. Therefore, alternative methods are continuously being developed as a strategy to be involved in integrated pest management programs. Thus, as part of our research on antifungals of plant origin, a group of botanical extracts was assessed for the respective inhibitory effect on mycelium and conidia of F. oxysporum. Mycelial growth inhibition was measured in 12-well plates containing amended semi-solid medium, whereas conidial susceptibility was determined through microdilution. The identification of the bioactive compounds among test extracts was performed using an indirect approach, consisting of the integration of chemical composition and antifungal activity datasets through single-Y orthogonal partial least squares (OPLS) regression. Results showed that Piper aduncum extract was the most potent mycelial growth inhibitor whereas P. elongatum exhibited the best effect on conidia susceptibility. The active compounds identified through statistical integration and subsequent isolation were piperaduncin C, asebogenin and (-)-methyllinderatin. These findings indicated that the integrative, indirect approach is useful for the identification of bioactive metabolites from botanical extracts to be further used as biological protective agents against this phytopathogen.

Entities:  

Keywords:  Fusarium oxysporum; botanical extracts; conidial susceptibility; mycelial inhibition

Year:  2021        PMID: 34961034      PMCID: PMC8705217          DOI: 10.3390/plants10122563

Source DB:  PubMed          Journal:  Plants (Basel)        ISSN: 2223-7747


1. Introduction

Plants are well-known factories and huge reservoirs of naturally-occurring compounds, many of them used by plants in ecological relationships to be able to relate and subsist [1]. These compounds, usually comprising specialized metabolites (formerly called secondary), are characterized by being biologically active and employed in defensive roles, among others, to maintain a natural balance with the environment, pathogens and predators [2]. Indeed, some of these metabolites are defensive barriers against microbial diseases, especially those caused by soil-borne fungal pathogens [3]. Among them, different Ascomycota fungi, particularly Fusarium species, are phytopathogens that affect several economically-important crops. In this group, Fusarium oxysporum is one of the most widespread pathogens globally, comprising more than 120 reported forma specialis [4]. This fungal phytopathogen can cause many losses through the vascular disease so-called ‘Fusarium Wilt’. Consequently, agronomic practices have been developed for controlling this disease, such as biological control, cultural practices and chemical control. The most common agricultural practice is oriented to chemical control by using synthetic fungicides since such a strategy is versatile and easily adopted [5]. Currently, the most used compounds to control the presence of this phytopathogen are mainly nitrogen-containing heterocyclic compounds, such as azoles, benzimidazoles, dithiocarbamates and dicarboximides [6]. However, this practice leads to environmental damage due to their toxicity [7] but promotes pathogen resistance. In this regard, the acquired resistance by phytopathogens to the available synthetic products makes their control increasingly more difficult [8]. This fact promotes abuse of the application of these fungicides and, consequently, generates their gradual loss of efficacy, causing the accumulation of such substances and altering the dynamics of the populations of soil-living microorganisms [9]. In addition, consumption of fruits and vegetables, previously treated with low or high doses of synthetic fungicides is also a cause of toxicity that impacts human health [10]. Several studies seek eco-friendly strategies to avoid perturbations of environmental dynamics, as well as the health of humans and animals. Alternative methods for the control of diseases have been studied with emphasis on compounds derived from plant sources, such as essential oils and botanical extracts, which can usually have higher safety for consumers and the environment or they can be efficiently incorporated as a part and/or phase of integrated pest management programs [11,12,13]. These plant end-products contain different types of metabolite classes, such as terpenoids (e.g., mono, di, triterpenoids and steroids), alkaloids, and phenolics (e.g., flavonoids, tannins, proanthocyanidins, and other phenolics-like compounds) [14]; however, they are selective and/or have specific roles in different ecological and endogenously biological events, so the exploration of such chemodiversity to look for antifungals from a particular plant source to control the fungal pressure on another plant is continually required through screening procedures [15,16]. Despite the activity exhibited by a botanical end-product, the active principles responsible for antifungal activity are not easily documented or recorded. Nevertheless, it is very important to identify those metabolites responsible for a particular effect in order to link the biological activity to a specific compound, even if the botanical extract would be employed. In this sense, there are several methods to establish their activity, either directly or indirectly. Within direct methods, bio-guided fractionation searches for the activity of depurated fractions from a parent extract to get the final identification of the bioactive components. However, this procedure is time-consuming and expensive [17]. On the other hand, indirect methods might overcome such disadvantages. An emergent indirect method to detect bioactives is based on the statistically-mediated integration of the chemical composition to be related to its biological activity [18,19]. In the present study, as part of our research on antifungals of plant origin, the inhibitory capacity on F. oxysporum growth of forty-four botanical end-products from an in-house plant collection was evaluated through mycelial growth on solid medium and conidial susceptibility in liquid medium. From the integration of these chemical and biological datasets, the bioactive constituents against F. oxysporum were then detected and identified.

2. Results and Discussion

2.1. Antifungal Activity of Test Botanical Extracts

Results on F. oxysporum mycelial growth inhibition (MGI) percentage at 0.2% (w/v) of all test extracts (n = 44) is presented in Table 1. The MGI covered was ranging from 12% to 95%, involving an average of 48.8% and a median of 54.08% (relative frequency of 0.38). Extracts showing the highest antifungal activity were found to be those derived from Piper plants, such as four extracts from Piper aduncum and P. elongatum (MGI > 76%), which were significantly different from the rest of the test extracts (p < 0.05). This result agrees with previous studies since various Piper plants are widely studied for their antifungal properties [20], even against F. oxysporum, such as P. hispidum (essential oil) [21] and P. nigrum (essential oil and extracts) [22]. Several specialized metabolites, such as lignans, neolignans, kavapyrones, flavones, flavanones and phenylpropanoids are closely related to Piper plants [23]. These compounds are considered to be responsible for various activities, such as antibacterial, antifungal, anti-inflammatory, antiplatelet, insecticide, antioxidant, cytotoxic, antiplasmodic, and antifungal activity against phytopathogens, such as F. oxysporum [22,24]. Indeed, some chemical differences depending on the plant part, phenology, environment, and genetic factors have been revealed for some Piper plants, influencing the biological activity of a particular plant source [20] and, consequently, expanding the scope of Piper-based products as a source of antifungals.
Table 1

Mycelial growth inhibition (MGI) of test botanical extracts.

#PlantBF aPP bC cMGI d (%)#PlantBF aPP bC cMGI d (%)
1 Piper aduncum PiLPaL95.26 ± 0.15 A24 Ulex europeus FLUeL50.76 ± 0.73 P
2 Piper elongatum PiLPeL91.31 ± 0.13 B25 Bursera simaruba BuLBsL49.74 ± 0.11 Q
3 Piper elongatum PiIPeI81.26 ± 0.21 C26 Croton fragrans ELCfL48.43 ± 0.09 R
4 Piper elongatum PiSPeS76.21 ± 0.11 D27 Croton hibiscifolius ELChL47.77 ± 0.23 RS
5 Anadenanthera peregrina FLApL70.08 ± 0.06 E28 Bursera simaruba BuBBsB47.63 ± 0.22 S
6 Nectandra longifolia LLNlL68.80 ± 0.07 F29 Galipea longiflora RuLGlL46.91 ± 0.30 T
7 Raphanus raphanistrum BrLRrL64.67 ± 0.13 G30 Ficus obtusifolia MoLFoL42.86 ± 0.13 U
8 Jacaranda obtusifolia BiLJoL62.71 ± 0.34 H31 Croton hibiscifolius ESChS41.96 ± 0.43 V
9 Nectandra acutifolia LLNacL62.66 ± 0.15 H32 Pyrostegia venusta BiSPvS41.03 ± 0.23 W
10 Protium heptaphyllum BuLPhL60.66 ± 0.47 I33 Baccharis macrantha ALBmL40.67 ± 0.13 W
11 Mimosa pudica FAMpA58.48 ± 0.23 J34 Phyllanthus salviifolius PhSPsS39.03 ± 0.05 X
12 Genista monspessulana FFGmF56.61 ± 0.18 K35 Virola peruviana MyLVpL38.73 ± 0.09 X
13 Mimosa nigra FA + FMnAF55.69 ± 0.02 L36 Trattinnickia rhoifolia BuLTrL36.86 ± 0.18 Y
14 Anadenanthera peregrina FBApB54.00 ± 0.07 M37 Mimosa pudica FLMpF27.01 ± 0.07 Z
15 Bowdichia virgilioides FLBvL52.35 ± 0.17 N38 Cedrela odorata MlLCodL24.02 ± 0.03 AA
16 Copaifera officinalis FBCoB52.25 ± 0.15 N39 Senna viarum FLSvL22.04 ± 0.15 AB
17 Hymenaea courbaril FLHcL52.21 ± 0.19 N40 Tithonia diversifolia AFTdF19.43 ± 0.31 AC
18 Croton colombianus ELCcL51.96 ± 0.23 N41 Virola elongata MyLVeL16.29 ± 0.04 AC
19 Mimosa colombiana FAMcA51.74 ± 0.16 N42 Hymenaea courbaril FSHcS14.28 ± 0.18 AE
20 Baccharis macrantha AFBmF51.71 ± 0.11 NO43 Cedrela odorata MlBCodB14.23 ± 0.09 AE
21 Miconia resima MtLMrL51.68 ± 0.11 NO44 Tithonia diversifolia ASTdS12.93 ± 0.18 AF
22 Nectandra amazonum LLNamL51.64 ± 0.05 NO- Dithane -- 99.1 ± 0.06
23 Cotoneaster pannosus RoFrCpFr51.02 ± 0.08 OP- Prochloraz -- 94.4 ± 0.36

a BF = Botanical Family: Pi = Piperaceae; F = Fabaceae; L = Lauraceae; Br = Brassicaceae; Bi = Bignonaceae; Bu = Burseraceae; E = Euphorbiaceae; A = Asteraceae; Mt = Melastomataceae; Ro = Rosaceae; Ru = Rutaceae; Mo = Moraceae; Ph = Phyllanthaceae; My = Myristicaceae; Ml = Meliaceae; b PP = Plant Part used to prepare the extract: L = Leaves; R = Roots; S = Stems; I = Inflorescences; A = Aerial part; F = Flowers; B = Bark; Fr = Fruits; c = Code assigned to each extract; d MGI = Mycelial growth inhibition expressed in percentage. The bioassay involved a final concentration of 0.2% (w/v) of each extract; Values presented as mean ± standard deviation (n = 3). Different superscript uppercase letters indicate significant differences according to the post hoc Tukey test (p < 0.05).

The most active and significantly different extract was P. aduncum (MGI = 95.3%). This plant has exhibited various activities, such as cytotoxic, antimicrobial [25], antifungal [26] and insect repellency [27]. In previous studies conducted on Fusarium species, the essential oil from P. aduncum showed important fungistatic action on Fusarium redolens and Fusarium solani [28]. In addition, P. aduncum showed activity against other species, such as Alternaria brassicicoli, A. chrysanthemi, Aspergillus flavus, A. fumigatus, Candida albicans, Cladosporium herbarum, C. sphaerospermum and C. cladosporioides [26,29]. Additionally, among test extracts, the MGI of other botanical end-products from Fabaceae, Lauraceae, Brassicaceae, Bignoniaceae and Burseraceae plants (involving nine extracts) also exhibited relevant inhibitory capacity (MGI > 55%), highlighting Anadenanthera peregrina and Nectandra longifolia leaves-derived extracts by their effect on F. oxysporum growth (MGI > 68%). Contrarily, extracts obtained from Cedrela odorata, Senna viarum, Tithonia diversifolia, and Virola elongata exhibited low inhibitory activity against F. oxysporum (MGI < 30%). The microscopic effect of the most active extract (i.e., P. aduncum leaves, PaL) on F. oxysporum mycelium was also recorded. In the control treatment, normal mycelial growth and shape was observed, including a normal spore production (Figure 1A). In contrast, dithane caused visible damage in fungal structures (Figure 1C), particularly related to hyphal damage and cytoplasm disintegration [30]. However, dithane also stimulated the overproduction of viable spores as a response to the fungicide in comparison to the control [31]. This outcome coincided with previous reports since the active principle mancozeb has been reported as a sporulation promoter on F. oxysporum [32]. Thus, despite the important inhibitory activity on mycelial growth, the sporulation stimulation by dithane could be considered an adverse effect on controlling the pathogen proliferation at the field level.
Figure 1

Microscopic visualization of F. oxysporum mycelium stained with lactophenol blue. (A) Normal growth of F. oxysporum mycelium (Control). 2000×. bar 25 μm. (B) Treatment with P. aduncum leaves-derived extract at 0.2% (w/v). 2000×. 25 μm. (C) Treatment with Dithane at 0.2% (w/v). 2000×. bar 25 μm. Features: (co) conidia, (cd) cytoplasm densification (lc) loss of cytoplasm, (cl) cross-linking of hyphae, (arrow) reduction and lysis, (dc) disintegration of cytoplasm.

In the case of P. aduncum, the effect was more evident even in comparison to the other test extracts and positive control, since several damages on fungal structures were observed. PaL-derived extracts caused loss of cytoplasm, cell reduction and lysis (Figure 1B), which suggested that the chemical components of this extract would target cell wall or cell membrane. Other effects were also detected, such as agglomeration, hyphal cross-linking, and considerable increase of vacuoles [33] and, finally, the spore production was reduced and the effect was found to be fungicide. These effects can be rationalized due to this active extract could contain lignans and flavonoids, common phytoconstituents reported for P. aduncum [34]. Such phenolic compounds can disrupt the cell wall of pathogenic fungi, promoting its osmotic lysis [35,36], and other subsequent fungal malfunctions and anomalies, as reported previously for phenolic-rich extracts and individual phenols against phytopathogenic fungi [37,38]. On the other hand, the conidial susceptibility on non-germinated F. oxysporum conidia suspensions for the entire set of extracts at 0.1% (w/v) was also evaluated. Since the assessment of conidial susceptibility through microdilution implies an indirect extent of conidial germination inhibition (CGI) of molds [39], it represented another fungal structure to observe the effect of test extracts. However, most extracts (86.4%, n = 38) exhibited no CGI at the test dose and they were, therefore, discarded. The remaining six extracts exhibited inhibitory activity, whose results are presented in Table 2, ranging from 15 to 84% GI. The most active extracts were P. elongatum leaves (PeL) (CGI = 83.5%) and T. diversifolia stems (TdS) (CGI = 74%), being significantly different (p < 0.05) to the other test extracts. Interestingly, the extracts with high inhibitory capacity on mycelial growth (i.e., PaL and PeS) exhibited low activity on conidial germination (CGI < 25). TdF-derived extract exhibited low activity on both mycelial and conidial susceptibility assays (<20%).
Table 2

Conidial susceptibility of active extracts.

PlantPlant Part aCode bCGI c (%)
Piper elongatum LPeL83.52 ± 0.78 A
Tithonia diversifolia STdS73.95 ± 0.18 B
Croton hibiscifolius SChS47.60 ± 0.11 C
Piper elongatum SPeS24.01 ± 0.15 D
Piper aduncum LPaL21.13 ± 0.02 E
Tithonia diversifolia FTdF15.36 ± 0.06 F
Dithane --97.36 ± 0.02
Prochloraz --53.62 ± 0.26

a Plant Part used to prepare the extract: L = Leaves; S = Stems; F = Flowers; b C = Code assigned to each extract; c CGI = Conidial germination inhibition expressed in percentage. The bioassay involved a final concentration of 0.1% (w/v) of each extract. Values expressed as mean ± standard deviation (n = 4). Different superscript uppercase letters indicate significant differences according to the Tukey test (p < 0.05).

The outcome from both methods (i.e., mycelial growth inhibition and conidial susceptibility) cannot be compared, due to two factors, i.e., the characteristics (e.g., cell wall composition or shape) of each fungal form [40] and exposition manner of extracts in each assay (i.e., submerged cultures vs. agar surface) [41], promoting considerable differences between them. However, F. oxysporum mycelium appeared to be more susceptible to most extracts under the conditions of the in-vitro test on amended solid medium, although only six extracts exhibited an in-vitro effect on conidia susceptibility under the submerged culture characteristics, possibly by solubility issues and/or selectivity to this fungal form. In this sense, the activity evaluation on these two fungal forms is very important to be evaluated as a combined/complementary information, considering the corrective aim of mycelial growth inhibition and the preventive scope of conidial germination [42]. In addition, owing to the homogeneity and quality of inoculum the major challenge of the microdilution assay for filamentous fungi, microscopic scrutiny of conidial/spore germination is recommended to verify the information provided by the conidial susceptibility indirectly measured by optical dispersion [41]. Accordingly, all six extracts effectively inhibited the conidial germination at different levels after microscopic inspection of treated liquid cultures in comparison to the control.

2.2. Integration of Chemical and Activity Datasets: Indirect Recognition of Bioactives

Chemical composition (based on chromatographic profiles) and antifungal activity (based on MGI) datasets were integrated through supervised statistics to indirectly recognize bioactives within test botanical extracts. They exhibited different profiles as expected, involving 125 differentiable signals. Some extracts shared particular signals having different intensities, but other signals were exclusive for a particular extract. The chromatographic profiles were decomposed into absorbance at 270 nm as a function of time (each 0.64 s) and a data matrix was then built (5064 × 44). The resulting data matrix was employed for the subsequent procedure. Thus, a supervised statistical analysis, by means of single-Y orthogonal partial-least squares (OPLS) regression (using MGI as continuous Y-variable), was used to integrate the chemical composition and biological activity of test plant extracts. The resulting statistical model (consisted of one predictive and one orthogonal component) could separate extracts, revealing an adequate explained variance (R2X = 0.78, R2Y = 0.82) and predictability (Q2Y = 0.46). The resulting scores plot (Figure 2A) showed the discrimination depending on the chemical composition but also according to the MGI data as a continuous Y-variable, comprising the first predictive component, t(1), versus the first orthogonal component, to(1), that explain the variations according to the MGI activity (37.2%) and chemical composition (40.8%), respectively. Such Single-Y-depending discrimination is intuitively visualized as a heat map representation (0–100% scaling) between high (red) and low (blue) MGI values. This two-factor discrimination was very important for our purpose since the scores plot revealed those extracts discriminated by chemical composition, but the chemical composition related to the MGI activity as a statistically important trend. Once the pattern recognition between datasets was found, the loadings were investigated according to their discriminating influence, using an S-line transformation. This S-line plot is a tailor-made visualization and interpretation tool for point-to-point decomposed 2D data (e.g., chromatographic profiles under ultraviolet-visible (UV-Vis) detection, infrared (IR) spectra or nuclear magnetic resonance (NMR) spectra) [43,44]. It is very useful to show the covariance loading (p(ctr)) along the chromatographic signals (i.e., variables expressed as time values) and colored according to the absolute value of the correlation loading, p(corr) [45], providing a linear indication of the correlation intensity. Hence, the single-Y OPLS-derived S-line plot visualized differences between least active (negative) and most active (positive) extracts (Figure 2B). Consequently, three metabolites (1–3) were found to influence (p(corr) > 0.5) the OPLS-based discrimination between most and least active extracts and, consequently, they were identified as the significant metabolites to the observed MGI. Compound 1 was the most significant metabolite (p(corr) = 0.75), and occurred in P. aduncum and P. elongatum extracts, whereas compound 4 exhibited good reliability but poor correlation loading (p(corr) = 0.34). Therefore, compound 4 was not considered a good candidate in the pattern recognition of the inhibitory activity on mycelial growth.
Figure 2

Single-Y orthogonal partial least squares (OPLS) as the integration tool for chromatographic data and mycelial inhibition of F. oxysporum (as continuous Y-variable) datasets. (A) Scores plot. (B) S-line plot. Extracts codification is related to the information presented in Table 1.

A similar procedure was employed to the SGI results. The corresponding single-Y OPLS model also separated extracts with suitably explained variance (R2X = 0.76, R2Y = 0.93) and predictability (Q2Y = 0.51) and led to the plots presented in Figure 3. Similarly, integration of conidial susceptibility and chemical datasets resulted in an adequate relationship along the t(1) (39.5%) versus to(1) (36.5%). Additionally, the respective S-line plot revealed that only compound 3 showed the best correlation (p(corr) = 0.70), being the most influencing variable for this SGI assay, whereas compounds 2 and 4 were more related to the least active extracts.
Figure 3

Single-Y orthogonal partial least squares (OPLS) as the integration tool for chromatographic data and conidial susceptibility of F. oxysporum (as continuous Y-variable) datasets. (A) Scores plot. (B) S-line plot. Sample codification is related to the information presented in Table 1.

Our findings indicate that a correlation between plant metabolite profiles and antifungal activity datasets can be effectively done through single-Y OPLS to recognize patterns under the decomposition of the spectral data into uncorrelated latent variables. OPLS (and even PLS) differs from principal component analysis (PCA) in the maximization of the covariance of independent variables (i.e., spectral data from IR, UV, or MS) as a function of a dependent variable (i.e., biological activity), either continuous or categorical [46]. Consequently, there is an increasing number of studies focused on the application of untargeted metabolomics to integrate the chemical composition and the activity of natural product mixtures [19,47]. Metabolomics-based approaches are actually employed to profile multiple mixture components simultaneously, typically through the application of chromatographic and/or spectroscopical analyses [46]. The use of metabolomics as the source of independent variables to be integrated with a dependent variable is the major advantage of this approach [19]. Indeed, it can also recognize unstable compounds that would be lost upon purification, which is the main challenge during fractionation procedures [48,49]. However, an innate restraint of chemical and biological dataset association is the recognition of false positives, since this integration does not have causal but correlative essence [50]. Therefore, statistically-identified bioactives are required to be fractionated or isolated to validate the correlative recognition [51]. In our case, the process of isolating the compounds with the highest statistical influence on the discrimination of the most active and least active extracts was undertaken in order to validate the correlative finding, since compounds 1–3 represented the best correlation values (p(corr) > 0.6).

2.3. Isolation and Identification of Antifungal Metabolites

The OPLS-based integration recognized compounds 1–3 as the most influencing metabolites in the antifungal activity from both assays (i.e., mycelial growth inhibition and conidial susceptibility of F. oxysporum). To validate this indirect recognition of potential bioactives, these compounds were purified by semipreparative HPLC separation from PaL and PeL-derived extracts and structurally elucidated by nuclear magnetic resonance (NMR). This analysis supported the unequivocal identification of these compounds (i.e., 1–3) as known metabolites since their 13C NMR profiles were identical to those reported for piperaduncin C (1) [52], asebogenin (2) [53] and methyllinderatin (3) [54], respectively. In the case of 3, its optical rotation showed the same sign (i.e., levorotatory) as that reported previously for (−)-methyllinderatin, isolated from leaves of P. aduncum [55]. Hence, the structures of these isolated, identified compounds are presented in Figure 4.
Figure 4

Structures of isolated compounds after OPLS-based recognition.

The IC50 values for the three purified compounds are presented in Table 3. Piperaduncin C (1) and asebogenin (2) exhibited the most potent antifungal effect through mycelial growth inhibition (IC50 = 38.2 and 25.6 μM, respectively), while (−)-methyllinderatin (3) showed the lowest activity (IC50 = 689.2 μM). In contrast, 3 exhibited the best activity in conidial susceptibility (IC50 = 22.3 μM), while 1 and 2 were inactive (>1000).
Table 3

Antifungal activity of isolated compounds from Piper species.

Piperaduncin C (1)Asebogenin (2)(−)-Methyllinderatin (3)
MGI IC50 (µM) a38.2 (31.5–44.8)25.6 (23.5–29.3)689.2 (623.8–744.9)
CGI IC50 (µM) b>1000>100022.3 (17.8–29.7)

a Half maximal inhibitory concentration (IC50 in μM) for the inhibition of F. oxysporum mycelial growth. b Half maximal inhibitory concentration (IC50 in μM) for the inhibition of F. oxysporum conidial germination. Data are expressed as best-fit value (95% confidence interval) (n = 4).

The three isolated compounds 1–3 shared the dihydrochalcone moiety but involved structural differences related to the hydroxyl substituent at ring B (in 2), and the dimeric and adduct forms, having the particular structural variation on ring A (in 1 and 3, respectively) (Figure 4). Piperaduncin C (1) is a dimeric dihydrochalcone metabolite which exhibited moderate antibacterial activity against Bacillus subtilis and Micrococcus luteus [52], whereas asebogenin (2) (4′-methoxy-2′,4,6′trihydroxydihydrochalcone) exhibited higher activity against these bacteria [52] but also against Staphylococcus aureus and methicillin resistant S. aureus [56], and antifungal activity against Candida albicans, C. krusei, C. parapsilosis and Cryptococcus neoformans (MIC < 15.6 µg/mL) [57]. Finally, (−)-methyllinderatin (3) is an interesting monoterpene-dihydrochalcone adduct and exhibited antibacterial activity against M. luteus [55]. However, the antifungal activity against Fusarium species of these compounds 1–3 has not been reported yet, so they are evaluated for the first time in the present study against mycelial growth and conidial susceptibility of F. oxysporum. The discovery of these compounds as antifungals was made possible by statistical integration of HPLC-based chemical composition and antifungal activity datasets, confirming that this approach is a valuable tool for identifying antifungals against F. oxysporum from a reasonable number of botanical end-products.

3. Materials and Methods

3.1. Preparation of Botanical Extracts

From an in-house collection of native and exotic plants sampled in different places of Colombia (n = 34), forty-four botanical extracts were prepared. Plants were collected in Meta, Casanare, Cundinamarca and Guaviare departments (coordinates 3.543, −73.669; 5.190, −72.547; 4.931, −74.008; 2.332, −72.616, respectively) between 2014 and 2017. Voucher specimens are kept at Colombian National Herbarium. The selected healthy plant materials (without visible damage) were separately air-dried and extracted using 96% ethanol at constant shaking speed (120 rpm) using a Heidolph Rotamax 120 platform orbital shaker (Heidolph Instruments GmbH & Co.KG, Schwabach, Germany). The extraction lasted one week with daily removal of the extract-containing solvent and replaced by fresh 96% ethanol. These mixtures were separated by filtration and the resulting solution was concentrated by distillation under reduced pressure at 40 °C using an IKA RV 10 Control rotary evaporator (IKA® RV 10, IKA® Werke GmbH & Co. KG, Staufen, Germany) to afford the raw extracts. Resulting raw extracts per plant from each daily extraction were collected, dried and subsequently stored at −20 °C until use.

3.2. In-Vitro Assays against F. oxysporum

F. oxysporum LQB-03, a virulent isolate obtained from wilting Physalis peruviana plants [58] was used as the test phytopathogen. This isolate has been preserved on Whatman paper # 1 at −20 °C, and further reactivated in potato dextrose agar (PDA) to be used in the antifungal assays. The in-vitro antifungal activity against F. oxysporum was evaluated through the inhibition of mycelial growth (12-well plate amended semi-solid medium assay) and conidial susceptibility (96-well plate microdilution assay). Both assays were performed using the respective monosporic culture of the test fungal isolate, developed in PDA (potato-dextrose-agar) medium for 8 days.

3.2.1. Mycelial Growth Inhibition Assay

A micro-scale amended medium protocol was performed following the previously reported procedure [59]. Briefly, 12-well plates (autoclavable glass) and semi-solid medium (1.2 g of PDB (potato-dextrose broth) and 0.5 g of Agar per 100 mL of distilled water) were used. The final volume (for treatments and controls) was 200 μL per well (1-cm diameter). The test concentration (i.e., 0.2% w/v) was prepared by supplementing fresh semisolid-medium with the required amount of each test dry, raw extract (n = 44) (i.e., the residue after extraction without solvent). A stock dispersion was reached by a direct mixture between the semi-solid medium (5 mL) and the required extract (10 mg). This mixture was vigorously stirred until achieving a homogenous dispersion before solidifying. Tween-20 (5%) was used to assist the dispersion of the extracts. The resulting homogeneously amended medium was added into three wells of the 12-well plate. Subsequently, a 1-mm agar-mycelial plug from 5-days actively growing cultures of F. oxysporum was inoculated onto the center of each well. Each 12-well plate was placed into a 17-mm Petri dish, under the appropriate conditions of humidity and sterility, and sealed with plastic films. Each trial comprised a randomized design with three replicates for each extract compared to an absolute control (untreated semi-solid medium). Sportak (prochloraz) and Dithane (mancozeb) were employed as positive controls using the same concentration (i.e., 0.2% w/v). After inoculation and sealing, this assembly was incubated at 25 °C. The assay was concluded once the colony on the negative control covered the whole well (after ca. 48 h). Mean colony area (mm2) was, therefore, measured for treated and untreated wells, under processing in the software Image J® using the respective photographic records. The percent mycelial growth inhibition (MGI) was then calculated for each replicate. This calculation was made employing this equation: % MGI = [(absolute control area − treatment area)/absolute control area)] × 100. Finally, a portion of the mycelium after being treated with botanical extracts was removed and stained with Lactophenol Blue. The stained fungal structures were visualized microscopically at 2000× using the Motic BA210 microscope (Motic, Carlsbad, CA, USA).

3.2.2. Conidial Susceptibility Assay

A microdilution protocol was implemented following the previously reported procedure [60]. The assays were carried out in 96-well plates by homogeneously mixing the test extracts in PDB liquid medium and DMSO (>0.2%) at 0.1% (w/v) as the final dose. Four replicates were adopted for each test extract. To prepare the non-germinated conidial suspensions, 1 mL of sterile distilled water (SDW) was added to a 9-mm Petri dish containing a 5-days actively growing culture of F. oxysporum. After that, an aliquot (100 µL) was placed onto the Neubauer chamber to perform the conidia counting. The final inoculum (1 × 106 conidia/mL) was adjusted using the appropriate amount of SDW. The experiment comprised the following mixtures: (1) Plant extract + conidia + PDB medium (treatment); (2) conidia + PDB medium (absolute control); (3) plant extract + SDW (blank 1); (4) PDB medium + SDW (blank 2). Treatment (180 µL) and previously prepared non-germinated conidia dispersion (20 µL) were combined to start the trial. SDW (20 µL) was added instead conidia dispersion for blanks 1 and 2. ProchlorazTM (iprodione) and Dithane FMBTM (mancozeb) were used as positive controls. The resulting optical dispersion (OD) values were taken at 0 and 8 h, using an Elisa EZ Read 2000 analyzer, recording at 600 and 680 nm. Due to the assessment of conidial susceptibility through 8-h microdilution from non-germinated conidial suspension assuming an indirect extent of conidial germination inhibition (CGI) of filamentous fungi [39], we opted to employ this indirect measurement. The calculation of CGI was carried out employing this equation: % CGI = [(ODcor absolute control − ODcor treatment)/ODcor absolute control)] × 100, where ODcor means OD values corrected with blanks 1 and 2. Finally, a portion of the conidia submerged cultures after treated with botanical extracts was removed and stained with Lactophenol Blue. The stained conidial structures were visualized microscopically at 2000× using the Motic BA210 microscope (Motic, Carlsbad, CA, USA) to verify the conidial germination and absence of hyphal structures.

3.3. High-Performance Liquid Chromatography Coupled to Diode Array Detector

Chromatographic profiles of test extracts were recorded on a Shimadzu Prominence (Shimadzu Corporation, Kyoto, Japan) equipped with two binary pumps, autoinjector, and a photodiode array detector. Each botanical extract was then dissolved in absolute ethanol (5 mg/mL) and injected (20 µL) into the HPLC system. The separation system consisted of a Synergi C18 column (Phenomenex, Torrance, CA, USA) (4.6 mm × 150 mm, 4 μm), and a combination of solvent A (1% formic acid in acetonitrile (ACN)) and solvent B (1% formic acid in Mili-Q H2O). A gradient elution method was used as follows: 0–2 min 0% B, 2–25 min 0% to 50% B, 25–35 min 50% B, 35–50 min 50% to 100% B, 50–55 min 100%, and 55–50 min 100% to 0% B, at 0.7 mL/min. The monitoring wavelength was 270 nm.

3.4. Statistical Analysis

A Shapiro–Wilk test was performed to determine the data normality of the inhibition percentage data. Once normality was verified, ANOVA tests were conducted on all samples (type I error, significance value p < 0.05) followed by post-hoc Tukey tests to determine the significant differences between data. These statistical tests were performed software R version 3.4.1 (R Foundation, Vienna, Austria). On the other hand, chromatographic profiles of the test extracts were exported to an ASCII 2D format and a matrix containing point-to-point HPLC data per extract sample was built (5428 × 44). This dataset was aligned in the Matlab® software (Vr2013a) (The Mathworks Inc., Natick, MA, USA). The aligned data were also normalized and autoscaled. These pre-treated chemical data (i.e., chromatographic profiles) were combined with the respective antifungal data (i.e., %MGC or %CGI) to assemble the integrated dataset. The resulting matrix was then imported into the SIMCA software (v 14.0) (Umetrics, Umeå, Sweden) to build the respective models by single-Y orthogonal partial least squares (OPLS). The obtained results were visualized by means of the scores and S-line plots.

3.5. Purification and Identification of Most-Active Compounds by Semipreparative-Scale HPLC

Portions of the PaL and PeL extracts (600 mg) were pre-treated with SPE Strata® C18-U cartridges (55 µm, 70 Å, 500 mg, 6 mL) (Phenomenex, Torrance, CA, USA). The most active microfractions were then collected using an UFLC Prominence system (Shimadzu, Columbia, MD, USA), operated in a semipreparative mode, consisting of a pump (LC-20AD), a column oven (CTO-20AC), a UV/Vis detector (SPD-20AV), an autosampler (SIL-10AP), a fraction collector (FRC-10A) and equipped with a reversed-phase Phenomenex Luna C18 column (250 × 10 mm, 5 μm) (Phenomenex, Torrance, CA, USA) at 20 °C. Ten consecutive injections of SPE-depurated extract (500 μL per injection, 80 mg/mL in MeOH) were separated at a flow rate of 3 mL/min using solvents A (1% formic acid in ACN) and B (1% formic acid in H2O) using an isocratic elution method. Targeted peaks, according to the OPLS-based recognition, were collected at retention time ranges 43.7–44.2 min (1.8 mg), 46.9–47.5 min (2.5 mg), and 47.9–48.4 min (2.1 mg), to afford pure compounds 1–3, respectively. Structures of isolated compounds were elucidated by 1H and 13C NMR, through the attached proton test (APT), on an Agilent DD2 600 MHz spectrometer (Bruker, Billerica, MA, USA) using CDCl3 as solvent. All shifts are given in δ (ppm) using tetramethylsilane (TMS) as internal standard. Coupling constants (J) in Hz. APT 13C NMR data of isolated compounds were identical to that reported for piperaduncin C (1) [52], asebogenin (2) [53] and (−)-methyllinderatin (3) [54,55]. Piperaduncin C (1). Amorphous yellowish solid. 1H NMR (CDCl3, 600 MHz) δH 10.55 (2H, s, OH-2′), 7.30 (2H, d, J = 7.3 Hz, H-4), 7.10–7.18 (8H, m, H-2, H-3, H-5, H-6), 6.15 (2H, s, H-3′), 3.98 (6H, s, CH3O-4′), 3.76 (2H, s, H-1″), 3.46 (4H, t, J = 7.7 Hz, H-7), 3.06 (4H, t, J = 7.7 Hz, H-8). APT 13C NMR (CDCl3, 150 MHz) δC 205.7 (C-9 × 2), 165.2 (C-2′ × 2), 161.3 (C-4′ × 2), 158.8 (C6′ × 2), 141.9 (C-1 × 2), 128.6 (C-2, C-6 × 2), 128.3 (C-3, C-5 × 2), 126.0 (C-4 × 2), 106.2 (C-3′ × 2), 104.5 (C-1′ × 2), 92.4 (C-5′ × 2), 56.5 (CH3O-4′ × 2), 45.8 (C-7 × 2), 30.4 (C-8 × 2), 15.7 (C-1″ × 1). HRESIMS [M + H]+ m/z 557.2166 (calcd. for C33H33O8, 557.2175). Asebogenin (2). White amorphous solid. 1H NMR (CDCl3, 600 MHz) δH 12.57 (1H, s, OH-2′), 7.07 (2H, d, J = 8.3 Hz, H-2,H-6), 6.55 (d, J = 8.3 Hz, H-3,H-5), 5.95 (2H, s, H-3′, H-5′), 3.74 (3H, s, 4′-OCH3), 3.25 (2H, t, J = 7.8 Hz, H-8), 2.76 (2H, t, J = 7.8 Hz, H-8). APT 13C NMR (CDCl3, 150 MHz) δC 205.5 (C-9), 166.2 (C-4′), 165.3 (C-2′, C-6′), 155.3 (C-4), 142.3 (C-1), 128.8 (C-2, C-6), 117.5 (C-3,C-5), 105.1 (C-1′), 92.5 (C-3′, C-5′), 56.2 (CH3O-4′), 46.1 (C-7), 30.2 (C-8). HRESIMS [M + H]+ m/z 289.1061 (calcd. for C16H17O5, 289.1076). (−)-Methyllinderatin (3). Colourless oil. [α]D20 = −39.4 (CHCl3, c = 0.01). 1H NMR (CDCl3, 600 MHz) δH 13.72 (1H, s, OH-2′), 7.27 (1H, d, J = 7.6 Hz, H-4), 7.05–7.13 (4H, m, H-2, H-3, H-5, H-6), 6.08 (1H, s, H-5′), 5.45 (1H, s, H-2″), 3.85 (1H, br d, J = 10.1 Hz, H-3″), 3.77 (3H, s, CH3O-4′), 3.36 (2H, t, J = 7.5 Hz, H-7), 3.02 (2H, t, J = 7.5 Hz, H-8), 2.16-2.08 (3H, m, H-6″, H-8″), 1.76 (3H, s, H-7″), 1.94 (1H, m, Hα-5″), 1.80 (1H, m, H-4″), 1.66 (1H, m, Hβ-5″), 0.85 (3H, s, H-9″), 0.79 (3H, s, H-10″). APT 13C NMR (CDCl3, 150 MHz) δC 205.5 (C-9), 165.1 (C-2′), 161.7 (C-4′), 159.7 (C6′), 142.1 (C-1), 134.9 (C-1″), 129.0 (C-3, C-5), 128.9 (C-2, C-6), 126.3 (C-4), 126.1 (C-2″), 107.7 (C-3′), 105.1 (C-1′), 92.1 (C-5′), 56.1 (CH3O-4′), 46.2 (C-7), 42.9 (C-4″), 35.2 (C-3″), 31.1 (C-6″), 30.9 (C-8), 29.3 (C-8″), 23.6 (C-7″), 23.3 (C-5″), 21.7 (C-10″), 17.8 (C-9″). HRESIMS [M + H]+ m/z 409.2388 (calcd. for C26H33O4, 409.2379).

4. Conclusions

Among test botanicals (n = 44), four Piper-derived extracts showed the most potent inhibitory activity on mycelial growth of F. oxysporum, whereas conidia were more susceptible to P. elongatum and T. diversifolia extracts, having moderate activity. This fact indicated a differential effect of extract components on each fungal form. Extract from leaves of P. aduncum exhibited the highest activity on mycelial growth, possibly targeting the cell wall or cell membrane of the fungus. The indirect detection of plausible bioactives through untargeted metabolic profiling, integrating the chemical and antifungal activity against F. oxysporum datasets, led to the recognition of three antifungal compounds piperaduncin C (1), asebogenin (2) and (−)-methyllinderatin (3) as the most active compounds. This finding was adequately validated after the isolation of these metabolites and evaluation of the pure isolates against F. oxysporum through both assays. This is the first report for these dihydrochalcone-type metabolites against F. oxysporum. Therefore, the usefulness of this indirect approach based on HPLC profiles for the identification of antifungals from botanical extracts was confirmed, which extends a rationale for less-time consuming antifungal recognition and lead finding from nature. Additionally, our findings constitute the basis for the development of antifungal agents based on active dihydrochalcone-containing extracts and individual compounds and, consequently, for outlining their potential as promising biorationals to protect plants against this phytopathogen.
  38 in total

Review 1.  Metabolomics for bioactivity assessment of natural products.

Authors:  Nancy Dewi Yuliana; Alfi Khatib; Young Hae Choi; Robert Verpoorte
Journal:  Phytother Res       Date:  2011-02       Impact factor: 5.878

2.  Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets.

Authors:  Olivier Cloarec; Marc-Emmanuel Dumas; Andrew Craig; Richard H Barton; Johan Trygg; Jane Hudson; Christine Blancher; Dominique Gauguier; John C Lindon; Elaine Holmes; Jeremy Nicholson
Journal:  Anal Chem       Date:  2005-03-01       Impact factor: 6.986

3.  Growth, hydrolases and ultrastructure of Fusarium oxysporum as affected by phenolic rich extracts from several xerophytic plants.

Authors:  Mahmoud S M Mohamed; Ahmed M Saleh; Ibrahim B Abdel-Farid; Sabry A El-Naggar
Journal:  Pestic Biochem Physiol       Date:  2016-11-19       Impact factor: 3.963

4.  Opportunities and Limitations for Untargeted Mass Spectrometry Metabolomics to Identify Biologically Active Constituents in Complex Natural Product Mixtures.

Authors:  Lindsay K Caesar; Joshua J Kellogg; Olav M Kvalheim; Nadja B Cech
Journal:  J Nat Prod       Date:  2019-03-07       Impact factor: 4.050

5.  Biochemometrics to Identify Synergists and Additives from Botanical Medicines: A Case Study with Hydrastis canadensis (Goldenseal).

Authors:  Emily R Britton; Joshua J Kellogg; Olav M Kvalheim; Nadja B Cech
Journal:  J Nat Prod       Date:  2017-11-01       Impact factor: 4.050

6.  Efficacy of ozone as a fungicidal and detoxifying agent of aflatoxins in peanuts.

Authors:  Ernandes Rodrigues de Alencar; Lêda Rita D'Antonino Faroni; Nilda de Fátima Ferreira Soares; Washington Azevedo da Silva; Marta Cristina da Silva Carvalho
Journal:  J Sci Food Agric       Date:  2011-09-23       Impact factor: 3.638

7.  Chemodiversity Associated with Cytotoxicity and Antimicrobial Activity of Piper aduncum var. ossanum.

Authors:  Yamilet Gutiérrez; Rodny Montes; Ramón Scull; Arturo Sánchez; Paul Cos; Lianet Monzote; William N Setzer
Journal:  Chem Biodivers       Date:  2016-11-23       Impact factor: 2.408

8.  Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study.

Authors:  G Palareti; C Legnani; B Cosmi; E Antonucci; N Erba; D Poli; S Testa; A Tosetto
Journal:  Int J Lab Hematol       Date:  2015-09-12       Impact factor: 2.877

9.  Gene Genealogies and AFLP Analyses in the Fusarium oxysporum Complex Identify Monophyletic and Nonmonophyletic Formae Speciales Causing Wilt and Rot Disease.

Authors:  R P Baayen; K O'Donnell; P J Bonants; E Cigelnik; L P Kroon; E J Roebroeck; C Waalwijk
Journal:  Phytopathology       Date:  2000-08       Impact factor: 4.025

10.  Microscopic study of the morphology and metabolic activity of Fusarium oxysporum f. sp. gladioli treated with Jatropha curcas oil and derivatives.

Authors:  L C Cordova-Albores; E Sandoval Zapotitla; M Y Ríos; L L Barrera-Necha; M Hernández-López; S Bautista-Baños
Journal:  J Microsc Ultrastruct       Date:  2015-11-02
View more
  3 in total

1.  Composition and Antifungal Activity of the Alkaloidal Fraction of Lupinus mirabilis Leaves: A Biochemometrics-Based Exploration.

Authors:  Freddy A Bernal; Ericsson Coy-Barrera
Journal:  Molecules       Date:  2022-04-29       Impact factor: 4.927

2.  The impact of chitosan on the early metabolomic response of wheat to infection by Fusarium graminearum.

Authors:  Myriam Deshaies; Nadia Lamari; Carl K Y Ng; Patrick Ward; Fiona M Doohan
Journal:  BMC Plant Biol       Date:  2022-02-19       Impact factor: 4.215

3.  Identification of Anti-Proliferative Compounds from Genista monspessulana Seeds through Covariate-Based Integration of Chemical Fingerprints and Bioactivity Datasets.

Authors:  Luis Díaz; Willy Cely-Veloza; Ericsson Coy-Barrera
Journal:  Molecules       Date:  2022-06-22       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.